Opportunity Information: Apply for RFA HS 10 004
Apply for RFA HS 10 004
- The Agency for Health Care Research and Quality in the health recovery act sector is offering a public funding opportunity titled "Recovery Act 2009 Limited Competition Innovative Adaptation and Dissemination of AHRQ Comparative Effectiveness Research Products (iADAPT) (R18)" and is now available to receive applicants.
- This funding opportunity was created on Oct 6, 2009 and posted on Sep 25, 2009.
- Applicants must submit their applications by Dec 16, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $29,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) County governments Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Private institutions of higher education State governments.
- Other Eligible Applicants include the following Faith based or Community based Organizations Indian/Native American Tribal Governments (Other than Federally Recognized).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Recovery Act 2009 Limited Competition Innovative Adaptation and Dissemination of AHRQ Comparative Effectiveness Research Products (iADAPT) (R18)," was issued by the Agency for Healthcare Research and Quality (AHRQ) using funds from the American Recovery and Reinvestment Act of 2009 (ARRA). The core goal is to push AHRQ's existing Comparative Effectiveness Research (CER) evidence further into real-world use by supporting projects that adapt, customize, and spread AHRQ CER Review products in ways that make them more usable, more accessible, and more likely to influence decisions in practice. Rather than paying for brand-new comparative effectiveness studies, the program focuses on getting more value and impact out of evidence products AHRQ has already produced through its Effective Health Care Program, especially the Comparative Effectiveness Research Summary Guides (CERSGs) developed by the John M. Eisenberg Center for Clinical Decisions and Communications Science.
The opportunity is built around a translation and dissemination problem: high-quality evidence often does not reach the people who need it in a form they can understand or in channels they actually use. CERSGs and related CER products are designed to bridge the gap between research and day-to-day decision-making by translating findings on the comparative effectiveness of clinical interventions for three key audiences: patients and consumers, clinicians, and policymakers. This FOA invites applicants to take one or more existing CER Review products (for example, full CER Reviews, Executive Summaries, or CERSGs) and create innovative adaptations that improve how the information is presented and/or how it is delivered, so it is more likely to be used, implemented, and acted upon.
A central emphasis is reaching populations that are often missed by mainstream dissemination approaches. The FOA explicitly highlights "difficult to reach" and underserved groups such as older adults, people with limited English proficiency, limited education, or limited insurance coverage, individuals from minority or immigrant communities, and people with health literacy challenges. It also includes other underserved populations who may have limited contact with the health care system or may not routinely access health information online or through traditional clinical pathways. In practical terms, proposals are expected to rethink format, language, medium, setting, and distribution channels to match how these communities actually receive and trust information.
The kinds of adaptations envisioned can vary widely, but they must be clearly tied to improving uptake and impact. On the clinician and health system side, the FOA suggests tailoring CER Review or Executive Summary content to specialized decision-making audiences such as Pharmacy and Therapeutics Committees or formulary committees, and integrating evidence into electronic environments like electronic medical records where clinical decision support tools could embed key findings at the point of care. On the patient and consumer side, the FOA points to adapting CERSGs for communities that may not rely on the internet for health information and may instead seek guidance through neighborhood networks, community organizations, or faith-based groups. Importantly, while CERSGs are a primary focus, applicants may supplement them with relevant details found in the underlying CER Reviews when needed to make the adapted products accurate and useful for the target audience.
Applicants are expected not only to develop and implement these adaptations, but also to evaluate them. The intent is to produce evidence about what dissemination and customization strategies actually work in specific settings and for specific audiences. The scope includes changes to content presentation (for example, readability, cultural tailoring, translation, visual formats, or audience-specific framing) and changes to delivery mechanisms (for example, embedding in clinical workflows, distributing through community intermediaries, or using non-digital channels). Overall, AHRQ is looking for practical, creative approaches that measurably increase awareness, understanding, use, and real-world impact of CER findings.
Administratively, this is a grant mechanism under the R18 Research Demonstration and Dissemination program. It was posted September 25, 2009, created October 6, 2009, and had an original and current closing date of December 16, 2009, with an archive date of January 16, 2010. The estimated total funding available was $29,500,000, with an award ceiling of $1,500,000 per award, and there was no cost sharing or matching requirement. The opportunity category is listed as "Other," with a funding activity category of Health and a funding instrument type of Grant. Eligible applicants include a broad mix of entities such as state governments, county governments, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized tribal governments, other tribal organizations, and additional eligible applicants including faith-based and community-based organizations (as clarified in the eligibility information). The funding opportunity number is RFA-HS-10-004, and full details were provided through the NIH grants guide posting linked in the announcement.
In plain terms, iADAPT is about taking trustworthy comparative effectiveness evidence that already exists and making it land better in the real world, especially in places and populations where traditional health communication fails. The program targets the last mile of evidence: converting reports and guides into tools, formats, and distribution approaches that fit the needs of clinicians, health systems, policymakers, and underserved communities, and then testing whether those adaptations genuinely change understanding, decisions, or use of evidence-based care.
Frequently Asked Questions (FAQs)
What is the iADAPT (R18) funding opportunity?
iADAPT stands for "Innovative Adaptation and Dissemination of AHRQ Comparative Effectiveness Research Products." It is a limited competition grant opportunity from the Agency for Healthcare Research and Quality (AHRQ) funded by the American Recovery and Reinvestment Act of 2009 (ARRA). The program uses the R18 Research Demonstration and Dissemination grant mechanism.
What is the main goal of this program?
The goal is to increase real-world use and impact of AHRQ's existing Comparative Effectiveness Research (CER) evidence by supporting projects that adapt, customize, and disseminate AHRQ CER products so they are more usable, more accessible, and more likely to influence decisions in practice.
Is this program funding new comparative effectiveness research studies?
No. The focus is not on creating brand-new comparative effectiveness studies. The focus is on getting more value and impact from CER evidence products AHRQ has already produced, especially products from AHRQ's Effective Health Care Program.
Which AHRQ products are most central to the iADAPT effort?
A key emphasis is on AHRQ Comparative Effectiveness Research Summary Guides (CERSGs) developed by the John M. Eisenberg Center for Clinical Decisions and Communications Science. Applicants may also use other existing CER Review products such as full CER Reviews and Executive Summaries.
What kinds of CER materials can be adapted under this FOA?
The FOA invites applicants to take one or more existing CER Review products (for example, full CER Reviews, Executive Summaries, or CERSGs) and create innovative adaptations that improve how the information is presented and/or delivered so it is more likely to be used and acted upon.
Can applicants add information beyond what appears in a CERSG?
Yes. While CERSGs are a primary focus, applicants may supplement them with relevant details from the underlying CER Reviews when needed to keep adapted products accurate and useful for the target audience.
What problem is iADAPT trying to solve?
The program is designed to address the translation and dissemination gap where high-quality evidence does not reach people in a form they can understand or through channels they actually use. The aim is to improve uptake and real-world impact by rethinking format, language, medium, setting, and distribution methods.
Who are the intended audiences for the adapted products?
AHRQ CER products are intended to support decision-making for three primary audiences: patients and consumers, clinicians, and policymakers. iADAPT encourages adaptations that make these products more effective for one or more of these audiences.
Which populations are specifically emphasized as priorities for dissemination?
The FOA places a central emphasis on reaching "difficult to reach" and underserved groups. Examples include older adults, people with limited English proficiency, limited education, or limited insurance coverage, individuals from minority or immigrant communities, and people with health literacy challenges. It also includes other underserved populations that may have limited contact with the health care system or may not routinely access health information online or through traditional clinical pathways.
What does "innovative adaptation" mean in this program?
"Innovative adaptation" refers to changing how existing AHRQ CER evidence is presented and/or delivered to make it more understandable, accessible, and actionable for the target audience. This can include changes to content presentation (such as readability, cultural tailoring, translation, visual formats, or audience-specific framing) and changes to delivery mechanisms (such as embedding information in clinical workflows or distributing through trusted community intermediaries).
Are projects expected to only create materials, or also to implement them?
Projects are expected to develop and implement the adaptations, not just produce materials. The intent is to move evidence into real-world use through formats and channels that fit the target settings and audiences.
Is evaluation required as part of an iADAPT project?
Yes. Applicants are expected to evaluate their adaptations. The intent is to generate evidence about which dissemination and customization strategies work in specific settings and for specific audiences, including whether they measurably increase awareness, understanding, use, and real-world impact of CER findings.
What are examples of clinician- or health system-focused adaptations mentioned in the FOA?
The FOA suggests tailoring CER Review or Executive Summary content to specialized decision-making groups such as Pharmacy and Therapeutics Committees or formulary committees. It also mentions integrating evidence into electronic environments like electronic medical records, including the potential for clinical decision support tools that embed key findings at the point of care.
What are examples of patient- and consumer-focused adaptations mentioned in the FOA?
The FOA points to adapting CERSGs for communities that may not rely on the internet for health information and may instead seek guidance through neighborhood networks, community organizations, or faith-based groups, using formats and distribution approaches aligned with how those communities receive and trust information.
Does the FOA allow non-digital dissemination approaches?
Yes. The FOA explicitly recognizes that some underserved communities may not routinely access health information online or through traditional clinical pathways, and it highlights the need for dissemination approaches that may include non-digital channels and trusted community settings.
What is the funding opportunity number for this announcement?
The funding opportunity number is RFA-HS-10-004.
Who is the issuing agency for this grant opportunity?
The issuing agency is the Agency for Healthcare Research and Quality (AHRQ).
What is the source of funds for iADAPT?
Funding for this opportunity comes from the American Recovery and Reinvestment Act of 2009 (ARRA), also described as the Recovery Act.
What is the grant mechanism and funding instrument type?
The mechanism is R18 (Research Demonstration and Dissemination), and the funding instrument type is a grant.
What is the estimated total funding available, and what is the maximum award size?
The estimated total funding available is $29,500,000. The award ceiling is $1,500,000 per award.
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
What is the opportunity category and activity category listed for this FOA?
The opportunity category is listed as "Other," and the funding activity category is Health.
Who is eligible to apply?
Eligible applicants include state governments, county governments, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized tribal governments, other tribal organizations, and additional eligible applicants including faith-based and community-based organizations (as noted in the eligibility information).
What are the key dates for this opportunity?
The opportunity was posted on September 25, 2009, created on October 6, 2009, and had an original and current closing date of December 16, 2009. The archive date is January 16, 2010.
Where were full details for the FOA provided?
Full details were provided through the NIH grants guide posting linked in the announcement.
What does success look like for an iADAPT project?
Success is aligned with practical, creative approaches that measurably increase awareness, understanding, and use of AHRQ CER findings, and demonstrate improved real-world impact by delivering evidence in formats and through channels that fit clinicians, health systems, policymakers, and underserved communities.
Browse more opportunities from the same category: Health Recovery Act
Next opportunity: Secondary Education, Two Year Postsecondary Education, and Agriculture in the K 12 Classroom Challenge Grants
Previous opportunity: Recovery Act 2009 Limited Competition AHRQ Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) Grants (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HS 10 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HS 10 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Recovery Act Beacon Community Cooperative Agreement Program Apply for HHS 2010 ONC BC 004 Funding Number: HHS 2010 ONC BC 004 Agency: Office of the National Coordinator Category: Health Recovery Act Funding Amount: $20,000,000 |
| American Recovery and Reinvestment Act of 2009, Information Technology Professionals in Health Care Curriculum Development Centers Apply for FOA OC HIT 10 001 Funding Number: FOA OC HIT 10 001 Agency: Office of the National Coordinator Category: Health Recovery Act Funding Amount: $3,000,000 |
| ARRA AHRQ Recovery Act 2009 Limited Competition PROSPECT Studies Building New Clinical Infrastructure for Comparative Effectiveness Research (R01) Apply for RFA HS 10 005 Funding Number: RFA HS 10 005 Agency: Agency for Health Care Research and Quality Category: Health Recovery Act Funding Amount: $3,000,000 |
| ARRA AHRQ Recovery Act 2009 Limited Competition Electronic Data Methods (EDM) Forum for Comparative Effectiveness Research (U13) Apply for RFA HS 10 006 Funding Number: RFA HS 10 006 Agency: Agency for Health Care Research and Quality Category: Health Recovery Act Funding Amount: Case Dependent |
| AHRQ ARRA Recovery Act 2009 Limited Competition AHRQ Mentored Clinical Scientists Comparative Effectiveness Development Award (K12) Apply for RFA HS 10 007 Funding Number: RFA HS 10 007 Agency: Agency for Health Care Research and Quality Category: Health Recovery Act Funding Amount: $850,000 |
| AHRQ ARRA Recovery Act 2009 Limited Competition AHRQ Institutional National Research Service Award (NRSA) Postdoctoral Comparative Effectiveness Development Training Award (T32) Apply for RFA HS 10 011 Funding Number: RFA HS 10 011 Agency: Agency for Health Care Research and Quality Category: Health Recovery Act Funding Amount: $900,000 |
| Recovery Act 2009 Limited Competition OS ARRA Comparative Effectiveness Research to Optimize Prevention and Healthcare Management for the Complex Patient (R21) Apply for RFA HS 10 009 Funding Number: RFA HS 10 009 Agency: Agency for Health Care Research and Quality Category: Health Recovery Act Funding Amount: Case Dependent |
| American Recovery and Reinvestment Act of 2009, Information Technology Professionals in Health Care Competency Examination for Individuals Apply for FOA OC HIT 10 002 Funding Number: FOA OC HIT 10 002 Agency: Office of the National Coordinator Category: Health Recovery Act Funding Amount: $6,000,000 |
| American Recovery and Reinvestment Act of 2009, Information Technology Professionals in Health Care Training Grants Furnishing Academic Program Development Assistance for University Based Training of Health Information Technology Professionals Apply for FOA OC HIT 10 003 Funding Number: FOA OC HIT 10 003 Agency: Office of the National Coordinator Category: Health Recovery Act Funding Amount: $6,000,000 |
| American Recovery and Reinvestment Act of 2009, Health Information Strategic Health IT Advanced Research Projects Apply for HHS 2010 ONC TR 005 Funding Number: HHS 2010 ONC TR 005 Agency: Office of the National Coordinator Category: Health Recovery Act Funding Amount: $18,000,000 |
| Recovery Act 2009 Limited Competition Expansion of Research Capability to Study Comparative Effectiveness in Complex Patients (R24) Apply for RFA HS 10 001 Funding Number: RFA HS 10 001 Agency: Agency for Health Care Research and Quality Category: Health Recovery Act Funding Amount: $500,000 |
| ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Clinical Trials (RC4) Apply for RFA OD 10 001 Funding Number: RFA OD 10 001 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: Case Dependent |
| ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Pilot Research (RC4) Apply for RFA OD 10 002 Funding Number: RFA OD 10 002 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: $500,000 |
| Recovery Act Limited Competition Comparative Effectiveness Research on Upper Endoscopy in Gastroesophageal Reflux Disease, Eradication Methods for Methicillin Resistant Staphylococcus aureus and Dementia Detection and Management Strategies (RC4) Apply for RFA OD 10 008 Funding Number: RFA OD 10 008 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: $500,000 |
| Recovery Act Limited Competition NIH Directors Opportunity for Research in Five Thematic Areas (RC4) Apply for RFA OD 10 005 Funding Number: RFA OD 10 005 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: Case Dependent |
| Recovery Act Limited Competition Methodology Development in Comparative Effectiveness Research (RC4) Apply for RFA OD 10 009 Funding Number: RFA OD 10 009 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: $500,000 |
| Recovery Act Limited Competition Research On Biosamples From Selected Diabetes Clinical Studies (RC4) Apply for RFA OD 10 010 Funding Number: RFA OD 10 010 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: Case Dependent |
| ARRA OS Recovery Act 2009 Accelerating Adoption of Comparative Effectiveness Research Results by Providers and Patients (R18) Apply for RFA AE 10 001 Funding Number: RFA AE 10 001 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: Case Dependent |
| Recovery Act Limited Competition Institutional Comparative Effectiveness Research Mentored Career Development Award (KM1) Apply for RFA OD 10 011 Funding Number: RFA OD 10 011 Agency: National Institutes of Health Category: Health Recovery Act Funding Amount: Case Dependent |
| ARRA OS Recovery Act 2009 Limited Competition Enhanced Registries for Quality Improvement and Comparative Effectiveness Research (R01) Apply for RFA HS 10 020 Funding Number: RFA HS 10 020 Agency: Agency for Health Care Research and Quality Category: Health Recovery Act Funding Amount: $4,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HS 10 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.